These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 758251)
1. Antiparkinsonian drug abuse: eight case reports. Rubinstein JS Hosp Community Psychiatry; 1979 Jan; 30(1):34-7. PubMed ID: 758251 [TBL] [Abstract][Full Text] [Related]
2. Dopaminergic activity of the antimuscarinic antiparkinsonian agents. Modell JG; Tandon R; Beresford TP J Clin Psychopharmacol; 1989 Oct; 9(5):347-51. PubMed ID: 2551932 [TBL] [Abstract][Full Text] [Related]
3. [Abuse of antiparkinsonian drugs among psychiatric patients]. Haggag A; Nissen T; Småbrekke A; Bratlid T Tidsskr Nor Laegeforen; 1986 Nov; 106(32):2734-6, 2753. PubMed ID: 3810596 [No Abstract] [Full Text] [Related]
4. Influence of anticholinergic-antiparkinsonian agents on the effects of narcoanalgesic drugs in the rat. Fischer E; Heller B; Lumbreras N Experientia; 1973 Feb; 29(2):188-9. PubMed ID: 4144250 [No Abstract] [Full Text] [Related]
5. Abuse of antiparkinsonism drugs. Feigning of extrapyramidal symptoms to obtain trihexyphenidyl. Rubinstein JS JAMA; 1978 Jun; 239(22):2365-6. PubMed ID: 642176 [TBL] [Abstract][Full Text] [Related]
6. Abuse of antiparkinsonian drugs. Craig DH; Rosen P Ann Emerg Med; 1981 Feb; 10(2):98-100. PubMed ID: 7224257 [TBL] [Abstract][Full Text] [Related]
7. Use or abuse of antiparkinsonian drugs by psychiatric patients. Saran AS J Clin Psychiatry; 1986 Mar; 47(3):130-2. PubMed ID: 2869028 [TBL] [Abstract][Full Text] [Related]
8. Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain. Katayama S; Ishizaki F; Yamamura Y; Khoriyama T; Kito S Res Commun Chem Pathol Pharmacol; 1990 Sep; 69(3):261-70. PubMed ID: 2236897 [TBL] [Abstract][Full Text] [Related]
9. USES AND ABUSES OF ANTIPARKINSONIAN MEDICATION. JEAN A; DONALD MW; BAN TA Am J Psychiatry; 1964 Feb; 120():801-3. PubMed ID: 14115476 [No Abstract] [Full Text] [Related]
10. Abuse of antiparkinsonian drugs by psychiatric patients. Macvicar K Am J Psychiatry; 1977 Jul; 134(7):809-11. PubMed ID: 869063 [No Abstract] [Full Text] [Related]
11. Effects of amantadine and of some synthetic antiparkinsonian drugs on the behavioral response to L-DOPA in mice. Florio V; Longo VG Physiol Behav; 1971 Apr; 6(4):465-6. PubMed ID: 5148760 [No Abstract] [Full Text] [Related]
17. [Therapeutic problems in the application of antiparkinsonian drugs in psychiatry]. Piasecki T Psychiatr Pol; 1996; 30(1):137-50. PubMed ID: 8722246 [TBL] [Abstract][Full Text] [Related]
18. Drugs of abuse and Parkinson's disease. Mursaleen LR; Stamford JA Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():209-17. PubMed ID: 25816790 [TBL] [Abstract][Full Text] [Related]
19. [A computer-assisted EEG study on psychotropic properties of antiparkinsonian drugs]. Suitsu N Seishin Shinkeigaku Zasshi; 1992; 94(3):238-62. PubMed ID: 1589555 [TBL] [Abstract][Full Text] [Related]